Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy

NCT05536297 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

278

Enrollment

INDUSTRY

Sponsor class

Conditions

Geographic Atrophy
Age-Related Macular Degeneration

Interventions

DRUG: avacincaptad pegol

Sponsor

Astellas Pharma Global Development, Inc.